3D Models Segment to Bolster In Vitro Lung Models Market Growth During 2025-2031

According to our new research study on "In Vitro Lung Models Market Forecast to 2031 - Global Analysis - by Type, Application, End User," the market was valued at US$ 446.35 million in 2024 and is projected to reach US$ 1,530.11 million by 2031; it is estimated to register a CAGR of 19.4% during 2025-2031. The report highlights trends prevailing in the market, and drivers and restraints pertaining to the market growth.

In vitro lung models offer more accurate simulations of human lung physiology than traditional 2D cultures. This advancement has attracted substantial investments from the public and private sectors. Emulate, a biotechnology company specializing in Organs-on-Chips technology, has attracted investments to commercialize human cell-based models that replicate organ-level functions. In September 2021, Emulate raised US$ 82 million in a Series E funding round led by the Founders Fund, underscoring the confidence in organ-on-chip platforms for drug testing and disease modeling. In December 2024, Newcells Biotech, a UK-based biotech startup specializing in the development of advanced in vitro models for drug discovery, secured US$ 1.60 million (